发明名称 |
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them |
摘要 |
The invention relates to salts of the active substance base 1-[N<SUP>2</SUP>-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine [BIBN4096] of formula I, the preparation thereof, a process for preparing an inhalation powder containing a salt of the active substance BIBN4096 as well as the inhalation powders which can be obtained by the process.
|
申请公布号 |
US6900317(B2) |
申请公布日期 |
2005.05.31 |
申请号 |
US20030365327 |
申请日期 |
2003.02.12 |
申请人 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
发明人 |
TRUNK MICHAEL;WEILER CLAUDIUS |
分类号 |
A61K38/00;C07D401/14;C07K5/06;C07K5/065;(IPC1-7):C07D403/14 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|